Quantifying Patient Preferences and Expectations About Diabetic Retinopathy Monitoring

Juan Marcos Gonzalez Sepulveda1,2, Jui-Chen Yang1, Alicja Mastylak1

  • 1Duke Clinical Research Institute, Durham, North Carolina.

JAMA Ophthalmology
|December 19, 2024
PubMed
Summary

Patient preferences for diabetic retinopathy (DR) monitoring do not align with expected benefits, contributing to low adherence rates. Understanding these gaps is key to improving DR monitoring and preventing blindness.

Related Concept Videos